These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 13103079)

  • 41. [Protoveratrine therapy of hypertension in hospital and ambulant practice].
    SCHLEISNER P
    Ugeskr Laeger; 1955 May; 117(18):559-64. PubMed ID: 13247433
    [No Abstract]   [Full Text] [Related]  

  • 42. Protoveratrine A in treatment of hypertension.
    GRAY IR; HAMER NA
    Br Med J; 1957 Sep; 2(5045):609-12. PubMed ID: 13460332
    [No Abstract]   [Full Text] [Related]  

  • 43. [Peroral protoveratrine therapy].
    KAINDL F; WATSCHINGER B
    Wien Z Inn Med; 1956 May; 37(5):191-6. PubMed ID: 13353182
    [No Abstract]   [Full Text] [Related]  

  • 44. A clinical comparison of two hypotensive drugs; newer ergot and veratrum alkaloids.
    ELEK SR; MCNAIR D; GRIFFITH GC
    Am Pract Dig Treat; 1952 Sep; 3(9):693-6. PubMed ID: 12986144
    [No Abstract]   [Full Text] [Related]  

  • 45. Oral protoveratrine in the treatment of hypertension.
    ALIMURUNG MM; GRAJO MZ
    Am J Cardiol; 1958 Sep; 2(3):361-71. PubMed ID: 13571173
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment of peripheral vascular diseases with hydrogenated alkaloids of ergot (hydergine)].
    GARCIA ZOZAYA R
    Rev Clin Esp; 1955 May; 57(4):235-41. PubMed ID: 13255203
    [No Abstract]   [Full Text] [Related]  

  • 47. An attempt to alleviate the emetic effect of protoveratrine by the concurrent use of chlorpromazine in the treatment of hypertension.
    CONNER PK; MCCONN RG; MOYER JH
    Am Pract Dig Treat; 1956 Jul; 7(7):1127-32. PubMed ID: 13327204
    [No Abstract]   [Full Text] [Related]  

  • 48. The use of protoveratrine in the treatment of hypertensive vascular disease.
    CURRENS JH; MYERS GS; WHITE PD
    Am Heart J; 1953 Oct; 46(4):576-92. PubMed ID: 13092044
    [No Abstract]   [Full Text] [Related]  

  • 49. The hydrogenated alkaloids of ergot (hydergine) in geriatrics; follow-up study.
    POPKIN RJ
    Am Pract Dig Treat; 1956 Oct; 7(10):1594-7. PubMed ID: 13362833
    [No Abstract]   [Full Text] [Related]  

  • 50. [Experiments with a new preoperatives test with hydergine].
    TALLONE G
    Acta Anaesthesiol; 1956; 7(4):293-322. PubMed ID: 13381323
    [No Abstract]   [Full Text] [Related]  

  • 51. Adrenolytic and sympatholytic action of certain dihydrogenated ergot alkaloids (hydergine) on dog kidney.
    KUBICEK WG
    J Appl Physiol; 1960 Jan; 15():109-14. PubMed ID: 14412398
    [No Abstract]   [Full Text] [Related]  

  • 52. Hydergine, a vasodilator; clinical report on hydergine in peripheral vascular disease.
    STICK WD
    Pa Med J; 1956 Sep; 59(9):1072-4. PubMed ID: 13359090
    [No Abstract]   [Full Text] [Related]  

  • 53. [Hydergine as a preanesthetic agent in ophthalmic surgery].
    BACCANINI P; BOSSO G
    Minerva Anestesiol; 1962 Jan; 28():45-8. PubMed ID: 13863689
    [No Abstract]   [Full Text] [Related]  

  • 54. The use of hydergine in the treatment of trophic ulcers in leprosy.
    FRITSCHI EP
    Int J Lepr; 1959; 27():216-20. PubMed ID: 13825274
    [No Abstract]   [Full Text] [Related]  

  • 55. [Studies on the effect of hydergine on isolated iris muscle preparation].
    BOROS B; TAKATS I
    Klin Monbl Augenheilkd Augenarztl Fortbild; 1959; 135():538-45. PubMed ID: 13802917
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effect of dihydroergotamine and hydergine on the lesser circulation in man].
    HALMAGYI D; IVANYI J; FELKAI B; ZSOTER T; TENYI M; SZUCS Z
    Magy Belorv Arch Ideggyogy Szle; 1952 Dec; 5(4):160-3. PubMed ID: 13131993
    [No Abstract]   [Full Text] [Related]  

  • 57. [Experimental cerebral histological lesions induced by Hydergine].
    MANCINI E; ROSSANO C; MONACI G
    Gaz Med Port; 1961; 14():490-7. PubMed ID: 14469142
    [No Abstract]   [Full Text] [Related]  

  • 58. [Cutaneous precapillaries in essential hypertension and in renal diseases and their modification following application of hydergine and thoracolumbar sympathectomy].
    GOMORI P; GABOR G; URAI L
    Magy Belorv Arch; 1950; 3(3):117-24. PubMed ID: 13131961
    [No Abstract]   [Full Text] [Related]  

  • 59. [Comparative studies on the mechanism of the effect of hydergine in dilating peripheral vessels].
    ADLER V; BARATH J
    Acta Med Acad Sci Hung; 1952; 3(4):379-84. PubMed ID: 13039931
    [No Abstract]   [Full Text] [Related]  

  • 60. [Sympathetic syndromes in rheumatology and their treatment by Hydergine. Apropos of about 100 cases].
    LANGERON L; VINCENT G; GARY R
    Rhumatologie; 1961; 13():209-13. PubMed ID: 14462134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.